ªÍŦSARS·P¬Vªºªí±³B²z
µo©ú¤H
HK ªLõ¥Á
¤@. µo©úI´º
¦Û2003¦~ªº2¤ë¥÷°_¡ASars ¹ïªÍŦªº¯f¬r·P¬V¬ðµM¥Ñ¤¤´ä¨â¦a¼sªx¶Ç¬V¡A¦º¤`²v°ª¹F15%¥ª¥k¡AÂå¾Ç¬É¨ÃµL¯S®ÄÃĪ«¦}¹ï¦¹¦Ó§ô¤âµLµ¦¡A¤¤°ê¡B»OÆW¡B»´ä¡B·s¥[©Y¡B¥[®³¤jµ¥§¡¥ý«á³Q¥@¬É½Ã¥Í²Õ´¦C¬°®È¹Cĵ§i°Ï¡A¸gÀÙ·l¥¢¼Æ¥H¤d»õp¡A¤HÃþªº¥Í©R²`¨ü¦º¤`®£©Æªº«Â¯Ù¡C
¦¹®É¡A¦p¦óªvÀøSARS ¹ïªÍŦªº¯f¬r·P¬V¦¨¤F¥@¬É¦U°êÂå¾Ç¬Éªº·í°È¤§«æ. µo©ú¤H¦b³oºò«æªºÃöÀYµo©ú¤F³Ì·sªºÂåªv¤è®×¡A¸Ó¤è®×爲¡§ªÍ³¡SARSªºªí±³B²z¡¨¡A±Ï¤H¬°²Ä¤@Àu¥ý¡Aµo©úªº¤¤¤å½Z©óMay.15,2003¶Ç¯uµ¹»´äªº¦æ¬Fªø©x¤Î¤¤°ê»â¾É¤H¡Aµo©úªº^¤å½Z¤]©óMay.20,2003¥ÑMey-Verme, Mrs. Sonia
(WDC)Âà¶Çµ¹'WHO-Padey'
; 'WHO-Liden'´f¤Î¥¿¦bGeneva¶}·|ªº¦U°ê½Ã¥Í³¡º»â¡C
¤G. §Ç ¨¥
¥ý±qªÍŦªº¥\¯à½Í°_¡C
ªÍªº¥Dn¥\¯à¦b©ó±N¥Ñ¥k¤ß«Ç®g¥Xªº¦å²G¸gªÍ°Ê¯ß¦A¤À°t¦Ü¦UªÍ°Ê¯ß¤À¤ä¨Ã¼s¤ÎªÍªwªº¤j¶q¤ò²Ó¦åºÞ±q¦Ó¶i¦æ®ðÅé¥æ´«¦ÓÀ£¤J®ñ®ð¤Î±Æ¥X¤G®ñ¤ÆºÒ¡AµM«á¥ÑªÍÀR¯ßªð¦^¥ª¤ß©Ð¦A¬ÛÃö¤ß²v¤ñ¨Òªº³t«×²V¦X¨ì¥k¤ß«Ç¡A¤HÅé¥D°Ê¯ßªº¤j´`Àô¹B¦æµÛ·sÂA§t®ñªº°Ê¤O·½´N¥Ñ¦¹¼ê´û¬u´é¡I(Fig.1.)
¥Ñ©ó®ðÅé¥æ´«ªº´C¤¶¨ÃµL¯S§O¤§³B¡A¤]¥¿¦p§Ú̦b¾i³½¤§®É¡A§âªÅ®ð¥´¤J¤ô©³産¥Í®ðªw¡AªÅ®ð¤¤ªº®ñ®ð¨Ì¾a»P¤W¤Éªº®ðªw¥~²y±ªºÄ²±¼¯À¿·»¤J¤ô¤¤¡C»P¾i³½¤¤ªº®ðªwµL²§¡A§Ú̪ºªÍªw¤Ñ¥Íºc¦¨¨ã³Æ¤F±µÄ²ªÅ®ðªº¼s¤j±¿n¡A´N¦b¨º¤p¤pªºªÍŦ¤º³¡¥Ñ©ó¦s¦bµÛ¶°±KªºªÍªw¤Õ²Õ´µ²ºc¡A¦]¦Ó¥O±µÄ²ªí±¼s¤j¦Ü70¢T¥H¤W¡I¨Ã¥B³o¨Ç²Ó¤Õ²Õ´ªºªí±§Gº¡·L¦åºÞ¡A´N³o麽¾á¥ôµÛ¡§´«®ñ¡¨ªº¥æ³q¨Ï©R¡AªÅ®ð¤]´N©¹¦å²G¡B¶¡½è¼h¤Î²ÓM¶¡ÂX´²§¹¦¨ªÍ´«®ð¡]Palmnary
Veneilation ¡^¡A³o¬O²{¥NÂå¾Ç¹ïªÍŦ³Ì°ò¥»ªº»{ÃÑ¡C
¹L©¹¡AªÍŦ¯e¯fªººØÃþÁc¦h¡A µ²®Ö¯f´¿¬O§xÃøªv¡ªº¶Ç¬V¯f¤]¦]¦hºØ§Ü¥Í¯ÀÃĪ«ªºµo©ú¡Aªv¡²v±µªñ¦Ê¤À¤§¦Ê¡I ¤p¨àªÍª¢¤]¬O¤@ºØ¥Dn±`¨£¯f¡A¨ä¥L¦p¨å«¬²Óµß©Ê¨Ò¦pªÍª¢Âù²yµß(pneumococcus) ¦Û¤£¥²¦h»¡¡A ¦Ó«D¨å«¬²Óµß©ÊªÍª¢ªº©ú¬PSARSªºªvÀøªk¤~¬O¤µ¤Ñªº¥DÃD¡C
º¥ý¬O¤¤ÂåÀøªk¡A¥u¥Ñ¸zG§l¦¬ªº¼Ò¦¡±N¬O¤¤Âåµo®iªºÏEÂê¡A¤¤Â媺ÃĤè¥u¦b¨ó§U¸zG¥h½E¸Ñ¬r´î§C¨xŦªº¨¯³Ò«×¡Aɦ¹´£°ªÅé¯à¼W±j§K¬Ì¤O¶È¦¹¦Ó¤w¡C
µM¦Ó¡A¥Ø«e¶EªvSARSªº¥D¬y¤´爲¦èÂ媺¨£¸Ñ¡A¦b¤¤°ê¦³¨£¥D±iÀ³¥Î¥|Àô¯À ¡B¬õÅð¯Àµ¥§Ü¥Í¯ÀªvÀø¡A »´ä°í«ù§Q¤Ú³ªL¡]Ribavirin¡^¤ÎÃþ©T¾J¡]steroid¡^¬O¦³®Äªº¤@½uªvÀøSARSªºÃĪ«¡A ¦ý¤@ª½¨Ï¥ÎRibavirinªº¥[®³¤j«Å§G°±¤î¥H¸ÓÃħ@爲ªvÀøSARSªº¨Ò¦æ¤è®×¦]爲¸ÓÃÄ¥i¯à産¥ÍªºÄY«°Æ§@¥Î¡C
¦ý¤£ºÞ¦p¦ó¡A±N§Ü¥Í¯À¥Ñ¸zG§l¦¬©Î¥ÑÀR¯ßª`®g³£¦n¡A ³£§ïÅܤ£¤F¦b¦å²G¤¤¹B¦æ§Üµß¦]¯Àªº¼Ò¦¡¡A §ÚÌ¥iÄy¦¹¯S¼xÂkÃþ爲¡§¦å²GÀøªk¡¨¡A«Ü¦h§Üµß¦]¯Àªº·L¤¸¯À¬OµLªk¥Ñ¸zG§l¦¬Âà¤Æ¡A¦]¦¹¡A½×Àø®Ä¨ÌµM¥Ñ¦èÂåÀøªk¿W¦û÷´ÀY¡I
¤]¦]¦¹¡A¤µ¤ÑÂå¬ì¬Éªº¦U¸ô¤H°¨µL¤@¤£¬O¥þ¯«³eª`¦a±N¬ì¬ãªº¤è¦V»EµJ¦b´£°ª¡§§Üµß¦]¯À¡¨ªºÃĮĺx´õ¤¤¥´Âà¡I
µM¦Ó¡A±qFig.2ªº¹Ï¥Ü¥i¥H±o¨ì啓µo¡A ¦p¦bªÍŦªº¦åºÞ°Ê¯ß´M§äÀRºw©Îª`®gÂI¡A¡§¦å²GÀøªk¡¨ªºÀø®Ä±N¤j´T´£°ª¡A¥Ñ¥D°Ê¯ß»PªÍ´`Àôªº¬y¶q¤ñ±N¬OÓ¥iÆ[ªº±`¼Æ¥i¥HÀò±oÃÒ¹ê¡A¥]¬ASARSªºÁ{§ÉªºÀø®Ä¹ê½îÀ³¥i±q³oùØÀò±o´£¤Éªº¾÷·|¡A ¦ý¤µ¤Ñ¡A§ÚÌ«on¦b¦¹«ü¥X¡AÂå¬ì¬É±Mª`SARS §Üµß¦]¯À¡§¦å²GÀøªk¡¨ªºÃĮħV¤O¤è¦V§¹¥þ¿ù¤F¡C
¦]爲¥²¶·¥HªÅ®ð爲¤¶±©w¸q¡A«D¨å¯fµß·P¬V(SARS)¤´µM¬O¤@ºØªí±©Ê¼ìºÅ·P¬V¡A ³o¬O¤@ӳзsªºÂå¾Ç©w¸q¡A±N¤ÞµoªÍŦÂåÀø²©R¡I ¦]¦¹¡A§Ú̧ó¨Ï¥Î¤F¤@Ó¤Q¤À¤u·~¬É²V¼ôªº«UºÙ¡A §Y¤Þ¤JªÍŦ·P¬Vªº§óª½±µªº¡§ªí±³B²z¡¨§Þ³N¡A¤]´N¬O»¡±N¦bªvÀø¤¤±N¤Þ¤J¶WÁnªi²M²z§Þ¥º¡I ¸Ü»¡¦^ÀY¡A¤]¥i²³æ¨Ó³o麽Á¿¡A¤ñ¦p¥~¥Ö½§²Óµß©Ê·P¬V¼ì¶§¡A¥unµµÃĤô¤@À¿±N³Ó¹L¥ô¦ó§Ü¥Í¯Àªº¡§¦å²GÀøªk¡¨ªº¯«¤¦§®Ãħa¡I
´N¦¹¦Ó½×¡A§Ú̧¹¥þ¥i¥H¼ÖÆ[¦a¶i¤@¨B¦a«ü¥X¡A¤@¥¹¦b¤µ¤Ñ¥DÃD±ÀÂ˪ºªÍŦ ¡§ªí±³B²z¡¨±o¨ìÂå¾Ç¬É±µ¤O¶}©Ý¬ãµo¦Ó¶i¤JÁ{§ÉÀ³¥Î¡A ¨º麽¡A¹ï©óSARSªì¨B·P¬VªÌ¨ÓÁ¿¡A¨ìÂå°|¬~¬~ӪͦӤw¡A¦Ó¨äºØÃþªº²Óµß©Ê¯f¬r¹ïªÍ³¡ªº·P¬V§ó¤£¦b¸Ü¤U¡A SARS´N±q¤µ¤Ñ°_¤£¦A¹ï¤HÃþ¦s¦bµÛ¥Í©Rªº¦M¯Ù¡I
¤µ¤Ñ¡AÂåªvSARS·P¬V¬O§ÚÌn½×zªº¥DÃD¡A¦Ó§Ú̥祲¶·¹ïSARSªºª«²zөʦ³Ó¤j·§ªºÁA¸Ñ¡G
1.
ªþ¹Ï3.¬Oºô¤W¤U¸üªº¹Ï¤ù¡A SARS¬O¤p©ó50¯Ç¦Ìªº¶W·L¯fµß¡ASARS¥Ñ¦h«aªºÅé§Î±o¦W¡AµM¦Ó¬O¦h«aªºª«²z¥ÍºAµ²ºc¨M©w¤F¥¦ªº§lªþ©Ê¡I¦Ó³oºØ§lªþ©Êªº§JªA¦b¥»³¹±j½Õªº¡§ªí±³B²z¡¨·P¬V¦³µÛ·¥¨ä«n·N¸q¡C ¨Ó¦Û³o¤@Æ[ÂIªº啓µo¡A¦b©I§l¹D¹w¨¾·P¬Vªº±¹¬I¤¤¨Ï§@ªÌ·Q¨ì¤F¿@ÆQ¤ôªºº¯³z©Ê¡A
¬O¶Ç²Îªº®ø¬r®øª¢§ó¬OÃo¤¤¤@Ä_¡A À³¸Ó«Ü®eÎï爲ªÀ·|©Ò±µ¯Ç¥h¹w¨¾ªýÂ_SARS±q¤fµÄ¡B«|³ï®É¬q¶Ç¼½¤ÎªÍ¡A爲²Óµß©Ê·P¬Vªº«|³ïª¢ªº¤HÌ¥un³Ü¤@¤fÆQ¤ô¼í¼í³ï¡A«|³ïª¢ªº¯kµh·Pı·|°¨¤W±o¨ì«Ü¦nªºµÎ½w¡A¹q¤l¤º¿sÃ誺Åã·L·|«Ü¤è«K¦a§i¶D§Ú̯u¬Û¡A¬O·P¬V¼ìºÅµoª¢ªº³¡¦ì²Óµß³QÆQ¤ô¡§¨R¨«¡¨´î¤Ö¤F¡C
2.
¶W·L¡B¶W»´ªº¯fµß¥u¯à¦b¹q¤lÅã·LÃ褧¤U¤~¯à²{§Î¡A¦ÓN95 ªº¹LÂo·¥¼ÐºÙ¬O 75¯Ç¦Ì¡A¡@¨Ï¶W·L¡B¶W»´ªºª«²z©Ê¥i¥H¥OSARSÀHµÛ¬y°ÊªÅ®ð¤¤ªº¤ô¥÷¯]¤l¡B¹Ð®J·LÁû²É¶Ç¼½¡A°w¹ï³oºØ¯S©Ê¡A§ÚÌ¥i¥H¨î©w¤@¨t¦Cªº¦³®Ä°w¹ï©Ê±¹¬I¡A¥]¬A¤@¥¹ÄƶiªÍ³¡ªº ¡§ªí±³B²z¡¨ªk¡C
¤T. ªÍŦ ¡§ªí±³B²z¡¨¤µ©õ±N¦³¤Ó¤è¦¡
1.
§Ü¥Í¯À®ð¤Æ§l¤JÀøªk¡F
2.
«ö¼¯¤Î¼QÀ¡«y¹ÂÀøªk¡F
3.
±NªÍ¸¨ú¥XÅé¥~·Àµß³B²z¡F
4.
ªÍ¸¤£¤Á°£¡A§½³¡«æá·Àµß³B²z¡F
5.
ªÍ¸ª`¤J·Àµß¾¯³B²z¡C
½×z¤@.
§Ü¥Í¯À®ð¤Æ§l¤JÀøªk¦´N¦s¦b¡A¦b·P¬Vªºªì´Á¦³¿n·¥§@¥Î¡A¦pªGÂà爲°ª¦MªºÂåÅ@§@·~®É¬q«e«áªº¨¾¬Ì±¹¬I¡A¥i¯à·|¦³¨}¦nªº®ÄªG¡A®ð¤Æªº§Ü¥Í¯À¤Æ¾Ç¯S©Ê¥²¶·Ý³Æ¬Û¹ï©ó37¢J¦³Àu¨}ªº·»¤ô©Ê¤~¨ã¦³µo®iªº«e´º¡C
½×z¤G.
«ö¼¯¼QÀ¡«y¹ÂÀøªk¤]ÄÝ©ó¡§ªí±³B²z¡¨¦Í¦C¤¤ªº¤@¶µ¡A ºÙª«²zÀøªk©Î¥i§ó¥[¾A¦X¡C ɥιïªÍ³¡¬I¥[·b°Ê¤O¨ÓÀ½À£ªÍªw¡A ¨Ï¯fµß²æÂ÷ªÍªwªº²ÓM¾À¡A±wªÌ±N»ó¤Õ´ÂµÛ¶§¥ú¥i¨ë¿E¼QÀ¡¨Ã¥ÑªÍ²`³B«y¥X¡A ¥u¥i¬ß±æ¦b·P¬Vªºªì´Á©Î¨¾½Ã±¹¬I¤¤ªºÓ¤H¨M©w¡A ¦]¦¹¥ú½u¼QÀ¡¾¹·|¦³¼s¤jªº¥«³õ¡A ¦]爲³o¤]¬O¯Ý¡BªÍ¸³¡¹B°Êªº¤@ºØ³Ì¨Î¤è¦¡¡A¨C¤Ñ¤TÓÀ¡¹ï¦Ñ¦~¤Hªº¾i¥Í¥ºªº´£¤É¤£¥i§C¦ô¡I ³oºØ¹B°Ê¤è¦¡ªº¦n³B¼È¤Ö¦³³Q¤H̵o±¸»{ÃÑ¡A¹ïªÍ®z¯fªÌ±N¬O¤@Өε¡A ¦ý¤wÃÒ¹ê·P¬VSARS³oºØ¦³±j¤j§lªþ¤Oªº¯fµß¡A¥ø¹Ï¥H¦¹´î»´¯fª¬¬O¤£²{¹êªº¡C
½×z¤T.
±NªÍ¸¨ú¥XÅé¥~·Àµß³B²z¡A¨Ã¤£¬O¤@Ó¤Û·Q¡A¯A¤Î¤FÅé¥~¦å²G¥[®ñ¾÷ªº«¤jµo©ú¤ÎÁ{§ÉÀ³¥Î¡C Åé¥~·Àµß³B²z¥i¥H¦³ÃIJG®ûªw¤Î·Å®t³B²z¨âºØ¤ÀÃþ¡A·Å®t³B²z¦Ü¤µ¥ç¬OÓ¥þ·sªºÂå¾Ç·§©À¡I ¤£¶È¥i¥H¥Î¦bªÍ³¡²Óµß©Ê·P¬V¡AÁÙ¥i¥Î©óÀù¯gµ¥¯f±wªÌ¡A¶W¶V¤FªÍŦ·P¬Vªºªí±³B²z½dÄw¡A¦p¯à§ó¦n¦aµo®i¡A±N¥i¥H§ó¦³®Ä¦a¦b¬YÃþ¯e¯fªºªvÀø¤¤¨ú¥N§Ü¥Í¯Àªº¦å²GÀøªk¡G
a.
Åé¥~ªºÃIJG®ûªw¤ñ°_Å餺ªºÃIJG®ûªw±N§óÑÆF¬¡©Ê¡A¥Ø«e¥i¿ï¾Ü¤£¶Ë®`ªÍ
ªw²Õ´ªº®ûªwÃIJG¤£¦h¨£©ÎªÅ¥Õ¡A ¦ý¥i±þµßªº®ûªwÃIJG¥iɧU¶WÁnªi¥R¤À
µo´§³Ì°ªÀø®Ä¬OÓ¦¨¥\±ªº»¤´b¡F
b.
¤°麽¥s·Å®t³B²z¡H ³Q³B²zªºªÍŦ¾¹©x¤Î¯fµß¦U¦³¤£¦Pªº¥ÍºA·Å«×¦±½u¡A¦b
³Q³B²zªº¾¹©x¥i´_¬¡ªº«æ³t§Ná·Å«×½d³ò¤º¿ï¨ú¥i¦b¦UºØ¯fµßªº¦º¤`ÂI¡A
³o´N¬O·Å®t®ÄÀ³ªº³B²z¤â¬q¡F ³oºØ³B²z¤â¬q¦bÂå¾Ç¤åÄmªº´£¥X¬O§_º¦¸¨Ã
¤£«n¡A ¹ê½îÃÒ©ú¨Ã¤£Ác½Æ¡AÃöÁä¬O«æ³t§N᪺³t«×¥ª¥kµÛ¾¹©xªº´_¬¡²v
³o¤@ÂI¤£¥i²¨©¿¡A¬Oȱo¦VÂå¾Ç¬Éªº¿n·¥±ÀÂ˪º±M®×¡C
½×z¥|.
ªÍ¸¤£¤Á°£§½³¡«æá·Àµß³B²z¡A¥ç¦P爲¨Ó¦Û·Å®t®ÄÀ³ªº²z½×¡A¬O¦b«e½×z¥|ªº§Þ¥º¼h¦¸¤W¶i¤@¨Bªº´£¤É¡C ¨ú¥XÅé¥~¦Ó¤£¤Á°£ªÍ°Ê¯ß¤ÎÀR¯ß¥i´î¤Ö¹ï´_쪺¶Ë®`¥H¤Î´î¤Ö¾¹©x¶¡¤§±µÄ²¨Ï§½³¡«æá·Àµß³B²z¨ã³Æ¥i¦æ©Ê¡A´NªÍŦ¨ÓÁ¿¦³Ãø«×ȱo¦Ò¼{¡A ¦ý¹ï©ó¨ä¥L¦pµÇŦµ¥¥i¡§¥bÂ÷Åé¾¹©x¡¨«æá·Àµß³N¬O¥i¦æªº¡A¦ý°ÝÃD´Æ¤âªº¬O«æá³]³Æ¤è¦¡¨Ã«D¬O²G®ò´`ÀôP§N¨º麽²³æ¡AÁ{§Én¨D¬O¦b5-10¬í¤º¥i±N¤j¬ù1 kgs ½è¶qªº¾¹©x°·Å¦Ü-30-50¢JªºP§N³]³Æ¦Ó¥B¬O±µÄ²¦¡¡A Âå¾Ç¤Wªº¬ð¯}±NµL¥i¶q¨ÃÄy¦¹¦V¬ì§Þ¬É´£¥Xn¨D¡C
½×z¤.
ªÍ¸ª`¤J·Àµß爲¤µ¤ÑªÍŦ·P¬Vªºªí±³B²zªº¥DÃD¡A§@ªÌ¨Ã«D¾ÇÂå±M¤~¡A¥u¾a´c¸ÉÂå¾Ç±`ÃÑ¡A ¨Ã·½¦Û¿@ÆQ¤ô¹ï¤fµÄ¡B«|³ïªí±³B²z®øª¢ªº·§©À啓µo¡A¥ç§ä¨ì¸û爲¦X¾Aªº·»¾¯¤Î·Àµß¾¯¡A«æ¶·¨üÁ{§ÉÀËÅç¡A¦ý§@ªÌ½T«H¡A©ÎªÌ¥un¥@¬É¤W±M·~ªº·»¾¯®v¤ÎÃľ¯®v¤@¥X¤â¡A¥O·»¾¯¤Î·Àµß¾¯¤è±¦A¦h¤@ÂI¿ï¾Ü¡ASARS ¯fµß¹ï¥Í©Rªº¦M®`±N¨ì¦¹爲¤î¡I
¥|. ªÍŦ¡§ªí±³B²z¡¨ªº³æ®ñÀøªk
¦bªÍ¤¤ª`¤J·»¸Ñ¤F®ø¬r¾¯ªº²GÅé¡A³o´N¬OªÍŦ³æ®ñÀøªkªºªí±³B²z²G¡C ¦¹²GÅé¾Ç¦W爲²GºAªº¥þ¬t¤Æ¦Xª«¡]Per fluoro
chemicals . PFC¡^¡A ®ø¬r¾¯«h爲¯ä®ñ¡C
³B²z²GÅé¿é°e¤JªÍ¸®É¾É¤J¶WÁnªi¥i¥H´£°ª§JªASARSªº§lªþ©Ê§Ö³t²M²zªÍ¤Õ¤¤ªº¯fµß¡A ³o¬O¥þ·s¹ê¥ÎªºÂåÀø¤è®×¡A ÃÄ®Ä産¥Í¬Oª½±µ±¹ïµÛSARS¯fµß²ÓMµo®gÁo©ú¨µ¯è¾É¼u¡A ¦Ó³o¾É¼uªº¦WºÙ¥¿¬O¥Ñ¯ä®ñªR¥Xªº³æ®ñ¡÷ O1¡A ¦]¦¹¥i¥H©R爲¡§³æ®ñÀøªk¡¨/ ¡§O1¡÷Therapy¡¨¡I
¦Ó¥Ø«e±`³Wªº§Ü¥Í¯À¸g¦å²G¥æ´«®ÄÀ³ªºÀøªk³Q¨ü¨î¦Ø¡A ¨Ò¦p¬O¦å²G¿@«×ªº¨î¡A ¤S¨Ò¦pªÍªw¤ò²Ó¦åºÞ¦ù¤Î¤£¨ìªº¶¡½è¼h³£¨¬¥HºÛÂÃÅé¿n50¯Ç¦Ì¤£¨ìªºSARS¯fµß¡A ¦]¦¹¡§¦å²GÀøªk¡¨¯d¤U¤F10%¥H¤W¦º¤`²vªº¾ú¥v¿ò«ë¡A ¦]¦¹¦èÂ媺¡§¦å²GÀøªk¡¨¤w±µªñ·¥¡C ¬Û¤Ïªº¡A¡§³æ®ñÀøªk¡¨産¥Í¤F±j¤jªºÃIJz®ÄÀ³¡A ¨Ã¹w´Áªº¦º¤`²v±N°¦Ü¹s¡G
1. PFE·»¾¯ªº¿ï¥Î¡F
2. ¯ä®ñ·Àµß¾¯ªº¯S©Ê¡F
3. PFC¡B¯ä®ñªº°t¨î;
4. ªÍŦ¡§ªí±³B²z¡¨³]p¬yµ{¡F
5. °Êª«ªÍŦ³B²zÅçÃÒ¡F
6. ¤â³N¥x³]pnÂI¡C
1. PFE·»¾¯ªº¿ï¥Î
¦b¿ï¾Ü²M²zªÍªwªº²GºA´C¤¶®É¡A§Ú̺¥ý·Q¨ì¤F¤@ºØ²GºAªº¥þ¬t¤Æ¦Xª«¡]Per fluoro
chemicals . PFC¡^¡A PFC¦b²GºA©I§l³N¦³²{¦¨Âå¾ÇÁ{§É¥i¥H°Ñ¦Ò¡A §Ú̧¹¥þ¥i¥HɥγoºØ©I§l²G·»¤J¦³®Äªº·Àµß¾¯©Î§Ü¥Í¯À²M²zªÍªwSARSªº·P¬V¡APFC¦³¦p¤U¨ô¶V¯S©Ê¡G
1.
PFC¥»¨¬O¤@ºØµL¦â¡BµL¨ý¡BµL¯äªº²GÅé¡A¤£¨ã¦³¬r©Ê¡F
2.
PFCªí±±i¤O§C¡A¤£·»¤_¤ô©ÎªÌ¬O¯×ªÕ¡F
3.
PFC¹ï©ó®ñ®ð¤Î¤G®ñ¤ÆºÒªº·»¸Ñ«×°ª¡A¨ã¦³°ª±K«×¥H¤Î§C·»¸Ñ«×ªº¯S©Ê¡A¹ï©ó¯ä®ñ¦³§ó°ªªº·»¸Ñ«×¡F
4.
PFC¦b«Ç·Å¤ÎÅé·Å¤U·|¦ÛµM´§µo¡A¤£·|¦]爲¥NÁ¦ÓÂàÅܦ¨¨ä¥Lª«½è¡F
¥þ¬t¤Æ¦Xª«(Per fluoro chemicals, PFC) ¦b¥»®×ªº³Ð·sÃĪ«À³¥Î¤¤爲±þ·ÀSARS¯fµßªº¯ä®ñ(O3)´£¨Ñ´åÂ÷³æ®ñªº²GÅ餶½è¡C¨ä¤À¤l¦¡爲C(5-18)F(12-38), ¤À¤lµ²ºcÃ쪺ªøµu¦b©óCªºÓ¼Æ¡A¬Û¹ïCªºÓ¼Æªº¤º¦bª«²z¯S½è¨M©w¤F¸Ó²GÅ餶½è¤£¦PªºªmÂI·Å«×(Boiling
Point C)¥i¥Ñ30¢J-215¢J¡C¥»µo©ú±À¤¶º¿ï爲C6F14 ¤Î C7F16¡A¦ý¹ê»Ú¤W¡AÁ{§É¤Wªº¿ï¾Ü±Nn¦Ò¼{ªº¦]¯À§ó¦h¡A¨Ò¦p¥H¹wp¤â³N»O¤W±þ·ÀSARS¯fµßªº®É¶¡¨Ó³W©w³æ®ñªº¿@«×¦A¤Îµû¦ôPFC¦bªÍ³¡´§µoªº®É¶¡¨Ó¿ï¨úµ¥µ¥¡F¦Ó«D¥þ¬t¤Æ¦Xª«ªºl¥ÍÅÜÅé²G¡A¨Ò¦pC5F9H3O«h¦b´£¨Ñ¹CÂ÷³æ®ñªº²GÅ餶½è®É¡A«h¥²¶·¥ýª`«³æ®ñ¹CÂ÷¿@«×¦]§@·~®É¶¡ªº°¸Ñ®ÄÀ³¡C
ÁaÆ[¤Wzªº¯S©Ê¡A°µ爲ªÍŦªí±³B²z²G¬O§¹¥þ¦X®æªº¡A¤@¤è±®ñ®ð¥i¥H¬ï³z¥¦¥OªÍªwªº®ðÅé¥æ´«¤£°±¤î¡A¦]¦¹PFC¥iºÙ爲°Ê¤O²GºA¡F ¥tªÌ¡A²GºAªº¥þ¬t¤Æ¦Xª«ªºº¯³z©Ê¥i¥H«OÃÒ¦bªÍªw¤¤µL¤Õ¤£¤J¡A ¯ä®ñ¦bPFC¤¤·»¸Ñ¤¤ªº³æ®ñì¤l«ê¦p¦n³B¦a¥i¥H°l´MSARSªºÂÜ迹¡F PFCªº¦ÛµMªº´§µo©Ê±o©ó«OÃÒ¤£·|¹ïªÍŦ産¥Í¥ô¦ó«á¿ò¯g¡F ¥tªÌ§ó¥[¥i¶Qªº¬O¥H·sÂAªºPFC²GÅ骺Äéª`»P¤Þ¬y¡A¥i¥H±NªÍ³¡¤ºªº¨ü·l²ÓM¥H¤Îµoª¢¤ÏÀ³©Ò³y¦¨²ÓM¸H¤ù¤ÎSARS«Íº´ÝÀeÄé¬~¥X¨Ó¡I
2. ¯ä®ñ·Àµß¾¯ªº¯S©Ê
1.
¯ä®ñªº¤À¤l¦¡¬OO3¬O°ª¯à¶q®ñ®ðªºÅܧΡA·»¸Ñ¤_¤ô¤Î¦UºØ²GºA¤Æ¦Xª«¡F
2.
§C¿@«×ª¬ºA¤U¬O¤@ºØµL¦â¡A¦³¯S®í¯ó¸{®ð¨ýªº®ðÅé¡A¦b°ª¿@«×¤U§e©úÅ㪺ÂŦâ®ðÅé¡A¤ñ«爲ªÅ®ðªº1.5¿¡F
3.
¯ä®ñªº®ø¬r°ò²z¦b©ó¯à°÷ÄÀ©ñ³æì¤l®ñ¥h®ñ¤Æ¯f¬rªº²ÓMÅé¡A¯}Ãa¨ä²ÓM®Ö¡A³Ñ¤Uªº¥¿¬O¯Â¥¿O2®ñ®ð¤]¥¿¬OªÍ³¡¤§¥Ì¬u¡F
4. ¯ä®ñ·»¤_¤ô¤¤«á¦³§ó±j¡B§ó§Öªº±þµß®ø¬r§@¥Î¡A¯ä®ñ¦P®É¥i¥H·»¸Ñ¦b²GºAªº¥þ¬t¤Æ¦Xª«§YPFC¦³µÛ¦W°ê»Ú¥Í産°Ó3m¤½¥q¤åÄmÃÒ¹ê(ª`1)¡F
5. ·í¯ä®ñªº¿@«×¶W¹L¤@©w¼ÆÈ«á¡A®ø¬r±þµß¬Æ¦Ü¥i¥HÀþ¶¡§¹¦¨¡F
¯ä®ñ¤Wzªº¯S©Ê§@爲ªÍªw·Àµß¾¯¬O¦X²zªº¿ï¾Ü¡A¤U¹Ï爲°ê»Ú¤W¤½»{¥Ñºô¤W¤U¸üªº¯ä®ñ·Àµß®ø¬rªº¹êÅç¸ê®Æ¡G
¯ä ®ñ ®ø ¬r |
§ë¥[¿@«× |
§ë¥[®É¶¡ |
¯f¬r¡B¯fìÅéºØÃþ |
±þ·À®Ä²v |
10mg/m3 |
20¤ÀÄÁ |
¤A«¬¨xª¢ªí±§Üì¡]HbsAg¡^ |
99.99% |
|
0.5ppm |
5¤ÀÄÁ |
¥Ò«¬¬y·P¯f¬r |
99% |
|
0.13mg/L |
30’ |
¯áÅè¦Ç½èª¢¯f¬rI«¬¡]PVI¡^ |
100% |
|
40£gg/L |
20’ |
¤j¸z±ìµß¾½µßÅéms2 |
98% |
|
0.25mg/L |
1¤ÀÄÁ |
·á½üª¬¯f¬rSA-H©M¤H½üª¬¯f¬r2«¬ |
99.60% |
|
* 12.6mg/L |
4¤ÀÄÁ |
«aª¬¯f¬r¡]Coronaviridae) |
100% |
|
4mg/L |
3¤ÀÄÁ |
¦ã´þ¯f¬r(HIV) |
100% |
|
8mg/m3 |
10¤ÀÄÁ |
¤äìÅé(Mycoplasma)¡B¦çìÅé(Chlamydia)µ¥¯fìÅé |
99.85% |
* ¼Ð»xµÛ¨C¤ÉªÍ³¡¡§ªí±³B²z¡¨²G12.6mgªº¿@«×§t¶q¥iµ¹§ÚÌ爲°Ñ¦ÒªºÀu¿ï¤¤ÂI¡C
3.
PFC¡B¯ä®ñªº°t¨î
PFC¡B¯ä®ñªº°t»s¤èªk¤Î¤u§@¬yµ{¨£¹Ï4. ¨ä¤¤¹Ï4.1爲®ñ®ð; ¹Ï4.2爲¯ä®ñ産¥Í¾¹;¹Ï4.3爲PFC·»²G; ¹Ï4.4爲»ÖªùÂà´«¾¹¡F¹Ï4.5爲®ð²G²V¦X¬¦¡F¹Ï6.6爲²V¦XÅø¡A¹Ï6.7爲¯ä®ñ¿@«×ªº¼Æ¦ì¦¡´ú¸Õ¾¹¨Ã¦³¿é¥X¨î°Ê²V¦X¬¦¤u§@ªº¯à¤O¡F¹Ï6.8爲²V¦XÅø²GÅé°ª«×³]©w¾¹¨Ã¦³¿é¥X¨î°ÊÂà´«¾¹ªº¯à¤O¡C
4. ªÍŦ¡§ªí±³B²z¡¨¬yµ{
³B²z¬yµ{¥H¥kªÍ³B²z¥Ü½d¡A¼È®É«O¯d¥ªªÍ©I§l¡A¥Ø¼Ð¬OÂùªÍ¦P®É³B²z¡A¥»µ{¦¡¤T.¦b¤HÅéÁ{§Éªº¯u¥¿¹ê½î¤§«e¡Aº¥ý¥²¶·¸g¹Lµ{¦¡¥|ªº°Êª«ªÍŦ³B²zÅçÃÒµL»~¤§«á¡A°Êª«ªÍŦ³B²zÅçÃÒÉų¤HÅé³B²z¬yµ{¤T¡A»¡©úµ{¦¡¤WªºË¸m¦n³B¬O¸`¬Ù®É¶¡¡AÂÔ¦b»¡©ú¡C
a. ªí±³B²zÁ{§É(³Â¾K®v±M·~¡AÅé¯à¥Í¤Æ´ú©w°£¥~)¥Ü·N¹Ï¡G
¨£ªþ¹Ï5.
b.
ªí±³B²zÁ{§É¹ê°È¤è®Ø:
¨£ªþ¹Ï6.
5. °Êª«ªÍŦ³B²zÅçÃÒ
°Êª«ªÍŦ³B²zÅçÃÒ¥H¨Å½Þ³æªÍ¦A¤Î¨âªÍ¦P®É³B²z¶¥¬q¡A °Êª«³B²z¥é¯uµ{¦¡¤T.ªº¤è®×¡A¦³¦p¤U¦w±Æ¡G
a.
¯ÂPFCª`¤JÅçÃÒ
ÀY |
¯ÂPFCª`¤J10
mins |
¯ÂPFCª`¤J30
mins |
¯ÂPFCª`¤J120
mins |
||||||
|
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
1 |
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
b. 12.6mg/L ·»¤JPFCª`¤JµLµß½ÞÅçÃҹﰪ¿@«×¯ä®ñªº¤ÏÀ³
ÀY |
¯ÂPFCª`¤J10
mins |
¯ÂPFCª`¤J30
mins |
¯ÂPFCª`¤J120
mins |
||||||
|
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
1 |
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
c. 25.2mg/L ·»¤JPFCª`¤JµLµß½ÞÅçÃҹﰪ¿@«×¯ä®ñªº¤ÏÀ³
ÀY |
¯ÂPFCª`¤J10
mins |
¯ÂPFCª`¤J30
mins |
¯ÂPFCª`¤J120
mins |
||||||
|
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
1 |
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
d.
12.6mg/L ·»¤JPFCª`¤JSARS½ÞÅçÃҹﰪ¿@«×¯ä®ñªº¤ÏÀ³
ÀY |
¯ÂPFCª`¤J10
mins |
¯ÂPFCª`¤J30
mins |
¯ÂPFCª`¤J120
mins |
||||||
|
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
¦å®ñ¶qÅÜ¤Æ |
¤ß¯ß·i °Ê¶q |
ªí·L ´yz |
1 |
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
ª`1. ¥H¤Wa-cªº¸ÕÅç爲ÅçÃÒPEC·»À٤绤J±þµß¾¯¯ä®ñ«áªº³B²z²GªºÃĩʬO§_¹ïªÍŦ¦³§_¤£¨}¤ÏÀ³¡A cªº¸ÕÅçÀ³¥i¥H±N¯ä®ñªº¿@«×¶i¤@¨B´£°ª¡Aª½¦Ü¦³¤@±ø¥i¾aªº½ÞªÍ¤ÏÀ³ªº¦±½u¹Ï爲¤î¡A¦¹¦±½u¹Ï¥i爲Ãľ¯®v¦b¤HÅé³B²z°t¤è¹º©w¸T°Ï§@°Ñ¦Ò¡C
ª`2.
d.ªº¸ÕÅçSARS¯fµßª¢¯g§@¹êÀËÅç¡A¶·n°ö¨|·P¬V¯f½Þ¡A¦UºØ¿@«×¾¯¶qªº´ú¸Õ¥H¦¹Ãþ±À¡A¦ý¹êÅç¨Å½Þªº§Ü¯f¤OÀ³»·¤j©ó¤HÃþ¡A¦ý¤@¯ë¨ÓÁ¿¡A·í³q¹L1-3ªºÃĪ«¤ÏÀ³¸ÕÅç«á¡A±þµß¾¯¶qªº¸ÕÅç¦b¸ÕºÞ¤¤¥ç¥i±o¥Xªñ¦üªºµ²ªG¡A¨Ã¥i¦b¹q¤lÅã·LÃè¤UÆ[±o¨ì¡A¥Í¤Æ¹êÅç«ÇÀ³¥i¦bµu®É¶¡¤§¤º爲Ãľ¯®v§@¥X«ü¤Þ³ø§i¡C ¥»¹êÅç³W¹ºÂÔ§@°Ñ¦Ò¡C
6.¤â³N¥xªº³]pnÂI
¤â³N»Oªº³]pnÂIÃöÁä¦b©ó¥i¥HÂà°Ê¤â³N¥xªº¤ô¥±¡A¥O¤â³N»O¤Wªº¤H¥i¥H¤À§O¥ª¥k°¼¨³Ì¤Ö45«×¡A¤è«K½ü¬y³B²z¥ª¥kªÍ³¡¡C
¤. µ² ½×
®Ú¾Ú¤Wzªº°Q½×¤Î±À²z¡A ¥HPFC²V¦X¯ä®ñªºÃĪ«¤è®×¥hÂåªvSARS¯f¬r·P¬V¬OªÖ©w¤Î¥þµM¨S¦³°Æ§@¥Îªº¡A³Æª`1-8ªº½×¤å/ºô¶¤ä´©¤F³o¤@µo©úªº±À²z¡A¦]¦¹¡Aµo©ú½T¹ê¥i¥H¬@±Ï¥Í©R¡Aµo©ú½T¹ê¦a§ïÅܤFªÍŦ¶Ç¬V¯e¯fªºÂå¾Ç¾ú¥v¡C
µo©úªº·Å®t³B²z®ÄÀ³ªº²z½×¤]¥i¥H¦b§¹¥þ¨S¦³°Æ§@¥Î¤U±þ¦ºÀù²ÓM¡AÂåÀøªº®ÄªG¬O¹qÀø¤Î¤ÆÀø©Ò±æ¹Ð²ö¤Îªº, 爲Àù¯g¯f¤H±a¨ÓºÖµ¡A¡§§NáÀøªk¡¨¦Ü¤µ¬OÓ¥þ·sªºÂå¾Ç·§©À, ¥þ·sªºÂåÀø¤èªk¡I
-§¹-
(ª`)°Ñ¦Ò¤åÄm/ºô¶:
1.
http://cms.3m.com/cms/US/en/2-68/iFcFiFM/view.jhtml
2.
http://www.vghtpe.gov.tw/~clinmed/ (¥Á°ê89¦~12¤ë´Á) [»O¥_ºa¥ÁÁ`Âå°|Á{§ÉÂå¾Ç¤é¥ZªÀ]
3.
Jeng MJ, Kou YR*, Sheu CC, Hwang B. Effects of Exogenous Surfactant
Supplementation and Partial Liquid Ventilation on Acute Lung Injury Induced by
Wood Smoke Inhalation in Newborn Piglets. Crit Care Med 2003; 31:1166-1174
4.
Jeng MJ*, Yang SS, Wolfson MR, Shaffer TH. Perfluorochemical (PFC)
Combinations for Acute Lung Injury: An in Vitro and in Vivo Study in Juvenile
Rabbits. Pediatr Res 2003;53:81-88.
5.
Jeng MJ*, Oliver R, Wolfson MR, Shaffer TH. Partial liquid ventilation:
effect of initial dose and redosing strategy in acute lung injury. Pediatr Crit
Care Med 2002;3:163-171.
6.
Jeng MJ*, Kou YR, Sheu CC, Hwang B. Effects of partial liquid
ventilation with FC-77 on acute lung injury in newborn piglets. Pediatr
Pulmonol 2002; 33:12-21.
7.
Jeng MJ*, Trevisanuto D, Weis CM, Fox WW, Wolfson MR, Shaffer TH. The
role of ventilation strategy on Perfluorochemical (PFC) evaporation from the
lungs. J Appl Physiol 2001; 90: 1365-1372.
8. Trevisanuto D,
Jeng MJ*, Weis CM, Fox WW, Wolfson MR, Shaffer TH. Positive end-expiratory
pressure modulates perfluorochemical evaporation from the lungs. Biol Neonate
2003;84:53-58.